Keles, S. Et Al. 2010. Clinical efficacy of subcutaneous immunotherapy and sublingual immunotherapy combination; 18 months of follow-up. 29th Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI) , (London, Canada), 265.

Keles, S., Karakoc-Aydiner, E., Ozdemir, C., Izgi, A., Tevetoglu, A., Akkoc, T., ... Bahceciler, N.(2010). Clinical efficacy of subcutaneous immunotherapy and sublingual immunotherapy combination; 18 months of follow-up . 29th Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI) (pp.265). London, Canada

Keles, S. Et Al. "Clinical efficacy of subcutaneous immunotherapy and sublingual immunotherapy combination; 18 months of follow-up," 29th Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI), London, Canada, 2010

Keles, S. Et Al. "Clinical efficacy of subcutaneous immunotherapy and sublingual immunotherapy combination; 18 months of follow-up." 29th Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI) , London, Canada, pp.265, 2010

Keles, S. Et Al. (2010) . "Clinical efficacy of subcutaneous immunotherapy and sublingual immunotherapy combination; 18 months of follow-up." 29th Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI) , London, Canada, p.265.

@conferencepaper{conferencepaper, author={S. Keles Et Al. }, title={Clinical efficacy of subcutaneous immunotherapy and sublingual immunotherapy combination; 18 months of follow-up}, congress name={29th Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI)}, city={London}, country={Canada}, year={2010}, pages={265} }